COVID-19 Pneumonia Classification Based on NeuroWavelet Capsule Network

Healthcare (Basel). 2022 Feb 23;10(3):422. doi: 10.3390/healthcare10030422.

Abstract

Since it was first reported, coronavirus disease 2019, also known as COVID-19, has spread expeditiously around the globe. COVID-19 must be diagnosed as soon as possible in order to control the disease and provide proper care to patients. The chest X-ray (CXR) has been identified as a useful diagnostic tool, but the disease outbreak has put a lot of pressure on radiologists to read the scans, which could give rise to fatigue-related misdiagnosis. Automatic classification algorithms that are reliable can be extremely beneficial; however, they typically depend upon a large amount of COVID-19 data for training, which are troublesome to obtain in the nick of time. Therefore, we propose a novel method for the classification of COVID-19. Concretely, a novel neurowavelet capsule network is proposed for COVID-19 classification. To be more precise, first, we introduce a multi-resolution analysis of a discrete wavelet transform to filter noisy and inconsistent information from the CXR data in order to improve the feature extraction robustness of the network. Secondly, the discrete wavelet transform of the multi-resolution analysis also performs a sub-sampling operation in order to minimize the loss of spatial details, thereby enhancing the overall classification performance. We examined the proposed model on a public-sourced dataset of pneumonia-related illnesses, including COVID-19 confirmed cases and healthy CXR images. The proposed method achieves an accuracy of 99.6%, sensitivity of 99.2%, specificity of 99.1% and precision of 99.7%. Our approach achieves an up-to-date performance that is useful for COVID-19 screening according to the experimental results. This latest paradigm will contribute significantly in the battle against COVID-19 and other diseases.

Keywords: COVID-19; capsule network; chest X-ray; convolutional neural network; pneumonia; wavelet.